Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1884 USD | -4.12% |
|
-7.60% | -24.55% |
05-15 | ReShape Lifesciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-15 | Transcript : ReShape Lifesciences Inc., Q1 2024 Earnings Call, May 15, 2024 |
Evolution of the average Target Price on ReShape Lifesciences Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering ReShape Lifesciences Inc.
Maxim | |
Alliance Global Partners |
EPS Revisions
- Stock Market
- Equities
- RSLS Stock
- Consensus ReShape Lifesciences Inc.